Literature DB >> 32242658

Structural Superiority of Guanidinium-Rich, Four-Armed Copolypeptides: Role of Multiple Peptide-Membrane Interactions in Enhancing Bacterial Membrane Perturbation and Permeability.

Jing Wang1, Chao Lu2,3, Yin Shi1, Xiaoqian Feng1, Biyuan Wu1, Guilin Zhou1, Guilan Quan2, Xin Pan1, Jianfeng Cai3, Chuanbin Wu1,2.   

Abstract

The development of novel antimicrobials is a top priority to address the growing epidemic of multidrug-resistant pathogens. Since cationic nonamphiphilic star-shaped antimicrobials are promising molecular scaffolds that provide a high charge density in binding anionic bacterial bilayers, this research aimed to further increase their membrane perturbation capability by introducing guanidinium groups to the antimicrobials via enhancing membrane insertion. In particular, computational simulation and experimental investigations revealed that our designed guanidinium-rich alternating copolypeptide, four-armed poly(arginine-alt-glycine), can interact with both the headgroups and unsaturated tails of phospholipids in bacterial membranes through multiple interactions, including electrostatic, cation-π, and T-shaped π-π interactions, allowing it to penetrate deeper inside the biologically inaccessible high-energy barrier of the hydrophobic lipid bilayer interior to cause membrane permeabilization and precipitation of the bacterial cytoplasm. Furthermore, glycine was observed to have a unique effect in enhancing the performance of arginine-based copolypeptide. Four-armed poly(arginine-alt-glycine) exhibited broad-spectrum antimicrobial activity, high bactericidal efficiency, and negligible hemolysis. The in vivo antibacterial performance of the copolypeptide was superior to that of doxycycline in a mouse model of Pseudomonas aeruginosa skin infection, accompanied by negligible local and systemic toxicity. Our results demonstrate that this guanidinium-rich, nonamphiphilic, star-shaped structure may promote the development of next-generation antimicrobials.

Entities:  

Keywords:  antimicrobial agent; guanidinium-rich copolypeptides; membrane perturbation and permeability; nonamphiphilic star-shaped structure; peptide−membrane interactions

Mesh:

Substances:

Year:  2020        PMID: 32242658     DOI: 10.1021/acsami.0c02752

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  5 in total

Review 1.  Antimicrobial Peptides and Cationic Nanoparticles: A Broad-Spectrum Weapon to Fight Multi-Drug Resistance Not Only in Bacteria.

Authors:  Giulia E Valenti; Silvana Alfei; Debora Caviglia; Cinzia Domenicotti; Barbara Marengo
Journal:  Int J Mol Sci       Date:  2022-05-29       Impact factor: 6.208

2.  Assessment of the safety of the cationic arginine-rich peptides (CARPs) poly-arginine-18 (R18 and R18D) in ex vivo models of mast cell degranulation and red blood cell hemolysis.

Authors:  Adam B Edwards; Frank L Mastaglia; Neville W Knuckey; Kwok-Ho Yip; Bruno Meloni
Journal:  Biochem Biophys Rep       Date:  2022-07-01

3.  Modular Design of Membrane-Active Antibiotics: From Macromolecular Antimicrobials to Small Scorpionlike Peptidomimetics.

Authors:  Minghui Wang; Xiaoqian Feng; Ruixuan Gao; Peng Sang; Xin Pan; Lulu Wei; Chao Lu; Chuanbin Wu; Jianfeng Cai
Journal:  J Med Chem       Date:  2021-04-01       Impact factor: 7.446

4.  Virus-inspired surface-nanoengineered antimicrobial liposome: A potential system to simultaneously achieve high activity and selectivity.

Authors:  Yin Shi; Xiaoqian Feng; Liming Lin; Jing Wang; Jiaying Chi; Biyuan Wu; Guilin Zhou; Feiyuan Yu; Qian Xu; Daojun Liu; Guilan Quan; Chao Lu; Xin Pan; Jianfeng Cai; Chuanbin Wu
Journal:  Bioact Mater       Date:  2021-03-11

5.  Metabolomics-Driven Exploration of the Antibacterial Activity and Mechanism of 2-Methoxycinnamaldehyde.

Authors:  Chunguo Qian; Lu Jin; Longping Zhu; Yang Zhou; Jing Chen; Depo Yang; Xinjun Xu; Ping Ding; Runnan Li; Zhimin Zhao
Journal:  Front Microbiol       Date:  2022-07-07       Impact factor: 6.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.